Score of 98.2/100 qualifies for PaymentCheck Certification
The average time taken for MEDICINES DISCOVERY CATAPULT LIMITED to pay invoices has remained relatively stable over the past three periods, with a slight increase from 16 days to 18 days. However, the percentage of invoices paid within 30 days has consistently remained high at 97-99%, indicating a strong commitment to timely payments to suppliers.
The volatility of MEDICINES DISCOVERY CATAPULT LIMITED's payment patterns is low, with a consistent trend of paying invoices within 30 days and minimal fluctuations in the percentages of invoices paid within 31-60 days and later than 60 days.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Apr 2023 - 30 Sept 2023 | 23 Oct 2023 | 17 | 99% | 1% | 0% | 0% |
| 01 Oct 2022 - 31 Mar 2023 | 28 Apr 2023 | 18 | 97% | 3% | 0% | 0% |
| 01 Apr 2022 - 30 Sept 2022 | 29 Nov 2022 | 18 | 99% | 1% | 0% | 0% |
| 01 Oct 2021 - 31 Mar 2022 | 21 Apr 2022 | 16 | 99% | 1% | 0% | 0% |
| 01 Apr 2021 - 30 Sept 2021 | 28 Oct 2021 | 16 | 97% | 2% | 1% | 1% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
30 days from invoice date
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
N/A
Maximum contractual payment period agreed
30
All disputes should be sent to finance@md.catapult.org.uk and will be responded to within 24 hours
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Medicines Discovery Catapult Limited is a research and development organisation based at Alderley Park, Macclesfield, working in biotechnology and pharmaceutical drug discovery. It is one of the managing partners of the CF AMR Syndicate, alongside the Cystic Fibrosis Trust and LifeArc, a government-funded, not-for-profit initiative that connects academia and industry to accelerate development of new antimicrobials and diagnostics for people with cystic fibrosis. Through this partnership it provides expertise, resources and grant funding, including a £3 million Collaborative Discovery Programme supporting early-stage drug discovery projects. The organisation helps bridge the gap between early scientific discovery and clinical translation, supporting researchers navigating regulatory and funding challenges in antimicrobial and diagnostic development.
Generated from the company's website and Companies House records. Sources: cfamr.org.uk · cfamr.org.uk